Literature DB >> 9881585

Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in the guinea pig.

J Goldhill1, I Angel.   

Abstract

The guinea pig colon was used to elucidate the mechanism of tachykinin-induced secretion. Increased short-circuit current was observed in response to natural and synthetic tachykinins with rank orders of potency of substance P > neurokinin A = neuropeptide K>> neuropeptide gamma; and senktide (tachykinin NK3 receptor agonist)> Sar-substance P (tachykinin NK1 receptor agonist)> betaAlaneurokinin A (tachykinin NK2 receptor agonist)). A functional role of tachykinin NK1 receptors was confirmed as substance P and neurokinin A responsiveness was blocked by the tachykinin NK1 receptor antagonist GR82334. The tachykinin NK3 receptor antagonist SB222200 had no effect, leaving in doubt the identity of the natural tachykinin NK3 receptor ligand in the colon. The response to tachykinin NK3 receptor activation was abolished by tetrodotoxin and predominantly due to atropine sensitive cholinergic activation. The non-cholinergic component resulted from stimulation of tachykinin NK 1 and 5-HT receptors as the response to senktide was blocked by GR82334 and tropisetron. In conclusion, tachykinin NK3 receptor activation stimulates cholinergic and non-cholinergic (tachykinin NK1-receptor and serotonin-mediated) secretory pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881585     DOI: 10.1016/s0014-2999(98)00797-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Cholinergic regulation of epithelial ion transport in the mammalian intestine.

Authors:  C L Hirota; D M McKay
Journal:  Br J Pharmacol       Date:  2006-09-18       Impact factor: 8.739

2.  Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease.

Authors:  D Moriarty; J Goldhill; N Selve; D P O'Donoghue; A W Baird
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 3.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

4.  Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling.

Authors:  Dang Q Dao; Erika E Perez; Yanfen Teng; John A Dani; Mariella De Biasi
Journal:  J Neurosci       Date:  2014-03-19       Impact factor: 6.167

Review 5.  An Endogenous Tachykinergic NK2/NK3 Receptor Cascade System Controlling the Release of Serotonin from Colonic Mucosa.

Authors:  Shu-ichi Kojima; Atsushi Tohei; Masashi Ikeda; Naohiko Anzai
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.